chevron_leftBack
As of 6 June 2026, Guangdong Jiaying Pharmaceutical Co., Ltd. has a market cap of $437.83M USD, ranking #16054 globally and #5047 in China.
It ranks #1445 in the Healthcare sector, and #80 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$437.83MUSD
2.96B CNY
Enterprise Value
$418.65MUSD
2.84B CNY
Revenue (TTM)
$56.69MUSD
383.75M CNY
EBITDA (TTM)
$9.74MUSD
65.97M CNY
Net Income (TTM)
$4.5MUSD
30.48M CNY
EBITDA Margin
17%
Profit Margin
7.9%
PE Ratio
97.2
PS Ratio
7.7
PB Ratio
4.1
EV/EBITDA
43.0
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Yong Ping You
open_in_new
Employees
594
Founded
2003
Website
gdjyzy.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -9.6% | -23% | -25% | -18% | -9.6% | -14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002198
广东嘉应制药股份有限公司 Class A
ISIN: CNE1000008P1
Shares Out.:
Shares Outstanding:
497.114M1
Shares Float:
315.471M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
5.84 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Guangdong Jiaying Pharmaceutical Co., Ltd.
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Shufeng Huoluo tablets, Tiaomeng Huoxue tablets, etc. Guangdong Jiaying Pharmaceutical Co., Ltd. was founded in 2003 and is based in Meizhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.86B
4K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.1B
2K%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.22B
1K%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.21B
861%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.27B
646%
22.12B CNY
|
8.1
|
|
|
$2.74B
526%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
9K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
7K%
|
-
|
|
NSE: CIPLA
|
$11.12B
2K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
2K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.79B
2K%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.43B
2K%
807.02B INR
|
23.1
|
chevron_leftBack